# Quercetin in Coronary Artery By-pass Surgery

> **NCT04907253** · PHASE2 · COMPLETED · sponsor: **Montreal Heart Institute** · enrollment: 100 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Quercetin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04907253
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-04
- **Primary completion:** 2023-12-01
- **Final completion:** 2025-05-16
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04907253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04907253, "Quercetin in Coronary Artery By-pass Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04907253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*